Get started
Author

Ivan M. Fushtey

Observed names: I Fushtey, I M Fushtey, I. Fushtey, I. M. Fushtei, I. M. Fushtey, I.M. Fushtey, Ivan Fushtey
ORCID: 0000-0001-5629-5264
Observed ORCID: 0000-0001-5629-5264
OpenAlex ID: A5108025175
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · Adrian F Hernandez, Jennifer B Green, et al. · The Lancet · 1,921
PDF
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
2019 · Hiddo J L Heerspink, Hans-Henrik Parving, et al. · The Lancet · 656
PDF
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
2022 · Peter Rossing, Stefan D. Anker, et al. · Diabetes Care · 242
PDF
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
2021 · Zien Zhou, Meg J. Jardine, et al. · Stroke · 127
PDF
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
2023 · Rajiv Agarwal, Wanzhu Tu, et al. · Annals of Internal Medicine · 125
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
2022 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 41
PDF
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
2023 · Tae Won Yi, Brendan Smyth, et al. · American Journal of Kidney Diseases · 37
PDF
Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
2022 · Alexander A. Berezin, Michael Lichtenauer, et al. · Frontiers in Physiology · 22
PDF
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
2018 · Jitendra PS. Sawhney, Veerappa A. Kothiwale, et al. · Indian Heart Journal · 21
PDF
The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
2023 · Alexander A. Berezin, Zeljko Obradovic, et al. · Biomedicines · 19
PDF
The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
2022 · Alexander A. Berezin, Ivan M. Fushtey, et al. · Biomedicines · 18
PDF
Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
2023 · Alexander A. Berezin, Anica Babic Obradovic, et al. · Journal of Cardiovascular Development and Disease · 14
PDF
Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure
2023 · Tetiana A. Berezina, Ivan M. Fushtey, et al. · Advances in Therapy · 13
PDF
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide
2022 · Sylvia Haas, John A. Camm, et al. · Clinical Research in Cardiology · 12
PDF
Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
2022 · Alexander A. Berezin, Ivan M. Fushtey, et al. · Journal of Cardiovascular Development and Disease · 12
PDF
Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
2022 · Alexander A. Berezin, Ivan M. Fushtey, et al. · Molecular Biomedicine · 9
PDF
The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection
2025 · I. M. Fushtei, V. O. Mochonyi, et al. · Zaporozhye Medical Journal · 3
PDF
Effect of RAAS genes polymorphism for recurrence of paroxysmal atrial fibrillation among patients with coronary heart disease combined with hypertension
2020 · I.M. Fushtey, S.G. Podluzhnyi, et al. · Biological Markers and Guided Therapy · 2
The State of the Sirs and Endothelial Function in Hypertensive Patients, Stage Ii in the Process of Ischemic Heart Disease Developing
2015 · I. M. Fushtey, V. A. Mochonyi, et al. · Zaporozhye Medical Journal · 2
Deformation of myocardium of the left ventricle for patients with ischemic heart disease with moderate dilatation of cavity of the left ventricle not complicated by the heart attack of myocardium
2014 · A. V. Molodan, I. M. Fushtey, et al. · Zaporozhye Medical Journal · 2
PDF
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897
2023 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 1
PDF
Utility of Irisin and Apelin in Prediction of Heart Failure Phenotypes in Type 2 Diabetes Mellitus Patients
2022 · Alexander Berezin, Ivan Fushtey, et al. · Journal of Hypertension · 1
Features of dyslipidemia and its influence on endothelium functional state in patients with rheumatoid arthritis and arterial hypertension
2021 · I. M. Fushtey, S. L. Podsevakhina, et al. · Modern medical technology · 1
PDF
Correction of Endotelial Dysfunction in Patients With Arterial Hypertension With Rheumatoid Arthritis
2020 · I. M. Fushtey, E. V. Sid’, et al. · Bulletin of Problems Biology and Medicine · 1
Predictors of Kidney Events in Type 2 Diabetes Mellitus Patients With Chronic Heart Failure Patients
2024 · Alexander Berezin, Ivan Fushtey, et al. · Journal of Hypertension
Works count: 60
Citation count: 3,302
H-index: 13
I10-index: 15
Year
Topic
Type